Satsuma Pharmaceuticals, Inc. Accumulated Other Comprehensive Income
Satsuma Pharmaceuticals, Inc. had Accumulated Other Comprehensive Income of -$5.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2023-05-11
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.00K.
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$30.00K.
- 2022-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$63.00K.
- 2022-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$107.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-03-31 | -$5.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$30.00K 10-Q · filed 2023-05-11 |
| 2022-09-30 | -$63.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$107.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$121.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$42.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | -$12.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$5.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $3.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $29.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $85.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $235.00K 10-Q · filed 2020-08-11 |
| 2020-03-31 | -$15.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $17.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $12.00K 10-Q · filed 2019-11-12 |